ShareValue scores for APLLTD.NSE: Valuation 67, Quality 48, Growth 57, Health 52.

Alembic Pharmaceuticals Limited logo

APLLTD.NSE
NSE

Alembic Pharmaceuticals Limited

₹828.95(+1.31%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

7% to 18%
Valuation
67
Fair Value
Price vs Value
Quality
48
Moderate
Business Strength
Growth
57
Moderate
Revenue & Earnings
Health
52
Moderate
Financial Stability
Momentum
58
Neutral
Price Trend

Company Details

About

Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026